课题基金 / 基金详情

Reducing Unused Prescribed Opioids After Cesarean Birth

Reducing Unused Prescribed Opioids After Cesarean Birth
减少剖腹产后未使用的处方阿片类药物
批准号:
10671569
负责人:
Sarah Scheiderich Osmundson
金额:
$16.88万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-07-31
关键词:
AbdomenAccidentsAcuteAnalgesicsAnesthesiologyAttentionAwardBiometryBirthCalibrationCaringCesarean sectionCessation of lifeCharacteristicsClinicalClinical InvestigatorClinical TrialsConduct Clinical TrialsDevelopmentDevelopment PlansDiscipline of obstetricsElectronic Health RecordElectronicsEmotionalEpidemiologyFamilyFamily memberFeelingFlushingFoundationsFriendsGoalsGuidelinesGynecologyHabitsHealth systemHeroinHospitalsIndividualInfantInterdisciplinary StudyInterviewK-Series Research Career ProgramsLeadershipLegalLocationMental DepressionMentorsMethodsMinorityMothersNational Institute of Drug AbuseOperative Surgical ProceduresOpioidOverdosePainPain MeasurementPain managementParameter EstimationPatient Outcomes AssessmentsPatientsPatternPersonsPharmaceutical PreparationsPostoperative PainProviderPublic HealthRandomized, Controlled TrialsReadinessRecommendationReportingResearchResearch PersonnelResearch TrainingRiskRoleSafetySamplingScholarshipSiteSmokingTestingTimeTrainingUnited StatesUnited States Food and Drug AdministrationWomanWorkcareercareer developmentchronic painclinical decision supportclinically significantdata toolseffectiveness studyexperienceillicit opioidimprovedinnovationinstrumentmultidisciplinarynonmedical useopioid abuseopioid disposalopioid epidemicopioid misuseopioid mortalityopioid overdoseopioid useoverdose deathpain outcomepain reliefpain scorepostcesarean sectionpredictive modelingpredictive toolsprescription opioidprogramsrandomized, clinical trialssatisfactionskill acquisitionstandard caresupport toolstooltreatment as usualtrial comparing

项目摘要

项目成果

Sarah Scheiderich Osmundson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Over the past 15 years, the United States has seen the emergence of an opioid epidemic with drug overdose ranking as the most common cause for accidental death. The rise in drug overdose deaths mirrors the rise in legal opioid prescribing. Unfortunately, most persons using opioids for non-medical purposes obtain them from a family member or friend who was legitimately prescribed opioids. While significant attention has been devoted to prescribing recommendations for individuals with chronic pain and for acute post-surgical pain, much less attention has been given to post-surgical opioid prescribing after hospital discharge. As the most common abdominal surgery in the United States, cesarean birth is the ideal setting to examine methods to reduce unused prescribed opioids. My preliminary work demonstrates that most women have unused opioids after cesarean birth, however a significant proportion of women use all opioids and have unmet pain needs. In addition, current opioid prescribing practices appear to be largely based on prescriber habits rather than patient need. This body of work endeavors to 1) characterize post-discharge opioid use patterns and identify demographic and obstetric variables associated with differential use 2) create and validate a clinical decision support tool that predicts customized post-discharge opioid need and 3) conduct a pilot randomized clinical trial comparing prescribing guided by the CDS tool to standard care to test whether this tool reduces unused opioids without increasing unmet pain after cesarean birth. The overarching objective of this mentored career development experience is to emerge as an independent clinical investigator leading a multidisciplinary research program to improve opioid prescribing after hospital discharge. To accomplish this goal, I will augment my prior research training with advanced coursework and skills development in predictive modeling and conducting clinical trials as well as leadership training focused on opioid prescribing and maternal and infant public health systems. Throughout the award period, the I will work closely with a multidisciplinary team of mentors and advisors—including experts in obstetrics and gynecology, biostatistics, anesthesiology, public health, and epidemiology—to carry out my stated career objectives and specific aims.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ajogmf.2021.100385
发表时间: 2021-07
期刊: American journal of obstetrics & gynecology MFM
影响因子: 6.3
作者: [Ha LC, Craig A, Grace MR, Osmundson SS, Taylor EW, Zuckerwise LC]
通讯作者: Zuckerwise LC
DOI: 10.1097/aog.0000000000004228
发表时间: 2021-02-01
期刊: Obstetrics and gynecology
影响因子: 7.2
作者: [Ende HB, Lozada MJ, Chestnut DH, Osmundson SS, Walden RL, Shotwell MS, Bauchat JR]
通讯作者: Bauchat JR
Case 1: Neonatal Trauma Following Motor Vehicle Collision in Pregnancy.
病例1:妊娠期机动车碰撞造成新生儿创伤。
DOI: 10.1542/neo.21-5-e342
发表时间: 2020
期刊: NeoReviews
影响因子: --
作者: [Shashy,LauraN, Craig,AmandaM, Sanlorenzo,LaurenA, Osmundson,SarahS]
通讯作者: Osmundson,SarahS
It's high time for intra-abdominal hypertension guidelines in pregnancy after more than 100 years of measuring pressures.
经过 100 多年的压力测量,现在是时候制定妊娠期腹内高压指南了。
DOI: 10.1111/aogs.13697
发表时间: 2019
期刊: Acta obstetricia et gynecologica Scandinavica
影响因子: 4.3
作者: [Lozada,MJames, Goyal,Varun, Osmundson,SarahS, Pacheco,LuisD, Malbrain,ManuLNG]
通讯作者: Malbrain,ManuLNG
9
    Comprehensive Postpartum Management for Women with Hypertensive Disorders of Pregnancy
    • 批准号:
      10708194
    • 项目类别:
    • 资助金额:
      $22.23万
    • 财政年份:
      2022
    • 负责人:
      Sarah Scheiderich Osmundson
    • 依托单位:
    Comprehensive Postpartum Management for Women with Hypertensive Disorders of Pregnancy
    • 批准号:
      10604847
    • 项目类别:
    • 资助金额:
      $26.59万
    • 财政年份:
      2022
    • 负责人:
      Sarah Scheiderich Osmundson
    • 依托单位:
    Reducing Unused Prescribed Opioids After Cesarean Birth
    • 批准号:
      10448490
    • 项目类别:
    • 资助金额:
      $16.97万
    • 财政年份:
      2019
    • 负责人:
      Sarah Scheiderich Osmundson
    • 依托单位:
    Reducing Unused Prescribed Opioids After Cesarean Birth
    • 批准号:
      10224161
    • 项目类别:
    • 资助金额:
      $17.06万
    • 财政年份:
      2019
    • 负责人:
      Sarah Scheiderich Osmundson
    • 依托单位:
    海外基金